立体定向海马-杏仁核损毁术治疗难治性癫痫致右动眼神经麻痹1例

2019-10-28 邱勇 乔旭 蔡永庆 中国临床神经外科杂志

女性,26岁,因反复发作反酸伴意识丧失14年入院。病人12岁起,反复出现发作性反酸,继之愣神、咂嘴、摸索,呼之不应,1~2min后意识丧失、口吐白沫、四肢抽搐,持续数分钟,单独或联合服用苯妥英钠、卡马西平、丙戊酸钠等药物无效,几乎每天都发作,多时每天6~7次。神经系统检查及头部MRI未见异常,长程视频脑电图监测到癫痫发作,发作期右颞叶首先出现棘-慢波并向双侧扩散,发作间期可见双侧慢波。诊断:难治性

1.病例资料
 
女性,26岁,因反复发作反酸伴意识丧失14年入院。病人12岁起,反复出现发作性反酸,继之愣神、咂嘴、摸索,呼之不应,1~2min后意识丧失、口吐白沫、四肢抽搐,持续数分钟,单独或联合服用苯妥英钠、卡马西平、丙戊酸钠等药物无效,几乎每天都发作,多时每天6~7次。神经系统检查及头部MRI未见异常,长程视频脑电图监测到癫痫发作,发作期右颞叶首先出现棘-慢波并向双侧扩散,发作间期可见双侧慢波。诊断:难治性癫痫,颞叶内侧型癫痫。
 
术前评估符合立体定向脑内核团射频毁损术标准:经两种及两种以上抗癫痫药物系统、规律、足量治疗两年以上,效果不佳;无严重精神衰退和脑萎缩,CT或MRI检查未见明确病灶;不适合或不接受癫痫灶切除手术治疗。
 
手术方法:1.5TMRI扫描(层厚3mm,层距0),图像输入计算机工作站,气管插管全麻后安装深圳安科公司ASA-602立体定向框架,行CT薄层轴位扫描,CT、MRI图像数据以Dicom格式输入Brain LAB iplan Stereotaxy手术计划系统,对CT、MRI图像和人脑图谱使用互感式点对点融合技术行靶点定位:右侧杏仁核X=21mm,Y=8mm,Z=-13.5mm;右侧海马X=20mm,Y=26mm,Z=0mm,术中通过COSMANRFG-1A射频治疗仪粗电极测电阻抗值辅助定位。使用2.1×7mm射频电极毁损靶点,温度75℃,时间60s,毁损灶大小约10mm×10mm×12mm。术后右上睑上抬无力,右眼球向外下方斜视,不能内收,外展功能正常,右眼球会聚不能,右瞳孔直径5mm、直接和间接对光反射迟钝,视物重影,视力及视野检查正常。头部CT示靶点位置正常,但毁损灶较预期大。诊断:右侧动眼神经麻痹。
 
给予营养神经、针灸等治疗。30d后,右上睑、右眼球运动及瞳孔大小恢复正常。术后随访1年,按Engel标准评价为Ⅱ级,继续服用抗癫痫药物治疗。
 
2.讨论
 
动眼神经麻痹主要表现为病侧上睑下垂、瞳孔散大、对光反射减弱或消失,病侧眼球除向外下运动外,其他各方向运动均麻痹,出现斜视、复视。动眼神经与杏仁核、海马头部在解剖上关系密切,动眼神经从大脑脚内侧发出,经钩回内侧进入海绵窦上壁。杏仁核构成钩回前段的绝大部分,到达前段上部的内侧面,海马头部的内侧面构成钩回后段的上部,前段和后段的汇合点即为钩回尖端,指向动眼神经。在海马-杏仁核毁损术中,一旦因定位误差、脑脊液流出所致脑组织移位、毁损参数的误差、个体差异等原因致使损毁范围超出预期大小或靶点位置出现偏差,使动眼神经容易受到热损伤。
 
本文病例由于毁损灶偏大造成右侧动眼神经不全麻痹。为避免类似情况发生,我们提出预防措施如下:①熟练掌握手术计划系统,确实实现CT与MRI图像融合,既克服CT图像分辨率低、影像不清晰的缺点,又避免MRI图像漂移带来的定位误差,使术前靶点定位成为真正意义上的可视靶点,提高颅内毁损靶点定位的准确性,把损伤重要神经传导束及功能部位的可能性降至最小;②设计手术入路时,尽量避免穿刺通道经过侧脑室,减少脑脊液流出,降低脑组织移位误差;③靶点定位个体化,当颞叶脑组织较小时,要调整电极或调整毁损参数,避免毁损灶相对较大;④采用局部麻醉,在清醒的状态下施行手术或先给予电刺激予以验证,一旦出现异常情况,立即停止毁损,将损伤降至最小。
 
立体定向射频毁损术操作简单、定位准确、损伤小。对颞叶癫痫部分性发作继发全身性发作的病人,尤其对癫痫发作伴有冲动、攻击行为,海马-杏仁核联合毁损术疗效比较肯定,动眼神经损伤的发生率很低,一旦发生,目前临床治疗原则除改善循环、消除水肿、神经营养外,针灸也有较好疗效。癫痫灶的准确定位对于提高手术疗效、降低副损伤具有决定性意义。
 
原始出处:

邱勇,乔旭,蔡永庆,徐海龙.立体定向海马-杏仁核损毁术治疗难治性癫痫致右动眼神经麻痹1例[J].中国临床神经外科杂志,2018(08):570.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2020-07-19 liao1632
  5. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 freve
  6. [GetPortalCommentsPageByObjectIdResponse(id=2043183, encodeId=4d462043183f2, content=<a href='/topic/show?id=e4103320e4e' target=_blank style='color:#2F92EE;'>#动眼神经麻痹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33207, encryptionId=e4103320e4e, topicName=动眼神经麻痹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Tue Nov 12 09:50:00 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986983, encodeId=9f411986983f9, content=<a href='/topic/show?id=e625332057a' target=_blank style='color:#2F92EE;'>#动眼神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33205, encryptionId=e625332057a, topicName=动眼神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Tue Jun 09 15:50:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986512, encodeId=bc721986512e0, content=<a href='/topic/show?id=160be5596d3' target=_blank style='color:#2F92EE;'>#立体定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75596, encryptionId=160be5596d3, topicName=立体定向)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Sep 19 12:50:00 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769064, encodeId=86f21e6906443, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Sun Jul 19 01:50:00 CST 2020, time=2020-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528612, encodeId=d4de1528612e8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540394, encodeId=da06154039438, content=<a href='/topic/show?id=48d6614666b' target=_blank style='color:#2F92EE;'>#杏仁核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61466, encryptionId=48d6614666b, topicName=杏仁核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53c913230719, createdName=paperyu, createdTime=Wed Oct 30 03:50:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 paperyu

相关资讯

JAMA Oncology:ASTRO 2017:LBA-3:立体定向消融放疗(SAbR)可提高NSCLC的PFS达三倍!

2017年的美国放射治疗年会在圣地亚哥举行,维持化学疗法之前立体定向消融放疗(SAbR)的固化治疗与单纯维持化疗相比,局限期的非小细胞肺癌(NSCLC)患者的无进展生存期(PFS)几乎翻了三倍。该文章也发表在JAMA Oncology上。

Lancet Onocol:立体定向放射手术或可治多发脑转移

脑转移是一种肿瘤患者常见的有生命危险的神经系统疾病。以往,脑转移患者的预后极差,主要采取姑息性治疗:激素和全脑放射治疗。然而,随着肿瘤系统治疗的进步,在控制良好的前提下,部分脑转移患者可以维持较好的神经功能,具有较长的生存期。 近日,日本Katsuta医院的Yamamoto教授等通过研究发现,立体定向放射手术或可成为具有10处及以下脑转移患者的治疗选择。相关研究结果发表在近期的《柳叶刀·肿瘤学》在

J. Thorac. Oncol.:立体定向消融放疗有望根除非小细胞肺癌

直到前不久,许多患有I期非小细胞肺癌(stage I non-small cell lung cancer)的老年患者都未接受过治疗,这是因为治疗可能并不改善他们的生活质量。然而,立体定向消融放疗(stereotactic ablative radiotherapy, SABR)已成为治疗这些病人的标准方法之一。给予为期两周的门诊治疗允许体弱的病人接受这种放疗。 研究人员想知道这种治疗在维持病人

立体定向手术治疗功能区灰质异位所致难治性癫痫

近年来,采用立体定向技术将深部电极植入颅内可疑致痫灶内及其周围,可准确判断致痫灶的位置及异常放电的传导路径,且可直接通过植入的深部电极进行射频毁损,消除致痫灶及阻断异常放电的传播路径,可以取得三个方面的效果:①若致痫灶较小,例如由体积较小的灰质异位或局灶性皮层发育不良所致的癫痫,可以达到完全控制发作的最佳效果;②根据毁损后癫痫发作减少的程度,可预判施行切除性手术的疗效,若毁损后癫痫发作减少50%以